Proteomics

Dataset Information

0

Quantitative Khib proteomic analyses of 20 cases of primary ESCC tumor tissue (T), matched normal tissue (N) and lymph node metastatic tissue (LN)


ABSTRACT: To obtain the global landscape of Khib in ESCC metastasis, 20 cases of primary ESCC tumor tissue (T), matched normal tissue (N) and lymph node metastatic tissue (LN) were subjected to quantitative Khib proteomic analyses.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Long Liao  

LAB HEAD: Bin Li

PROVIDER: PXD038252 | Pride | 2026-06-29

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Search.rar Other
YD209LP2o_P001_LN_Slot1-20_1_18255.d.zip Other
YD209LP2o_P001_N_Slot2-21_1_18212.d.zip Other
YD209LP2o_P001_T_Slot2-1_1_18172.d.zip Other
YD209LP2o_P002_LN_Slot1-21_1_18257.d.zip Other
Items per page:
1 - 5 of 61
altmetric image

Publications

2-Hydroxyisobutyrylation and Phosphorylation Crosstalk Guides Metastasis Prediction and Immunotherapy in Esophageal Squamous Cell Carcinoma.

Li Junyi J   Li Shujun S   Yu Xiaomei X   Mu Qier Q   Luo Maowen M   Wang Yuzhen Y   Liu Zhichao Z   Gu Chengwei C   Chen Jiaxi J   He Wangcheng W   Yang Tong T   He Yan Y   Pei Xiaoya X   Lin Mao M   Li Zhigang Z   Liu Jun J   Zhao Baosheng B   Zhang Fan F   Liu Jinbao J   Li Bin B   Xu Wenwen W  

MedComm 20260619 7


Posttranslational modification (PTM) is pivotal in cancer progression. However, the mechanisms, biological function, and clinical significance underlying PTM crosstalk are unclear. Here, we performed systematic analyses of 2-hydroxyisobutyrylation (Khib), phosphoproteomic, proteomic, and transcriptomic profiles from 60 esophageal squamous cell carcinoma (ESCC) samples, comprising matched normal, primary tumor, and metastatic lymph node tissues. The integrative analysis identified 4499 proteins c  ...[more]

Similar Datasets

2026-06-29 | PXD037295 | Pride
2022-04-04 | PXD022499 | Pride
2022-09-01 | PXD029503 | Pride
2022-12-31 | PXD012666 | Pride
2025-03-18 | PXD061812 | Pride
2021-12-30 | PXD028116 | Pride
2020-12-10 | PXD013781 | Pride
2021-10-01 | PXD023011 | Pride
2021-01-15 | PXD023013 | Pride
2024-01-16 | PXD022064 | Pride